Lehne's Pharmacotherapeutics for Advanced Practice Providers 2nd Edition Test Bank – Complete Chapters 1-24

ChapterV1:VPrescriptiveVAuthorityVTestVBankVMul
tipleVChoice
1. AnVAPRNVworksVinVaVurologyVclinicVunderVtheV
supervisionVofVaVphysicianVwhoVdoesVnotVrestrictVtheVtyp
esVofVmedicationsVtheVAPRNVisVallowedVtoVprescribe.VS
tateVlawVdoesVnotVrequireVtheAPRNVtoVpracticeVunderVp
hysicianVsupervision.VHowVwouldVtheVAPRN‘sVprescripti
veVauthorityVbedescribed?
a. FullVauthority
b. Independent
c. WithoutVlimitation
d. LimitedVauthority


ANS:VB
TheVAPRNVhasVindependentVprescriptiveVauthorityVbecauseVtheVregulatingVbodyVdoesVnotV
requireVthatVtheVAPRNVworkVunderVphysicianVsupervision.VFullVprescriptiveVauthorityVgive
sVtheVproviderVtheVrightVtoVprescribeVindependentlyVandVwithoutVlimitation.VLimitedVauthor
ityVplacesVrestrictionsVonVtheVtypesVofVdrugsVthatVcanVbeVprescribedV.DIF:VCognitiveVLeve
l:VComprehensionVREF:Vp.
1TOP:VNursingVProcess:VIVMSC:VNCLEXVClientVNeedsVCategory:VPhysiologicVInte
grity:VPharmacologicVandVParenteralVTherapies
2. WhichVfactorsVincreaseVtheVneedVforVAPRNsVtoVhaveVfullVprescriptiveVauthority?


a. MoreVpatientsVwillVhaveVaccessVtoVhealthVcare.
b. EnrollmentVinVmedicalVschoolsVisVpredictedVtoVdecrease.
c. Physician‘sVassistantsVareVbeingVutilizedVlessVoften.
d. APRNVeducationVisVmoreVcomplexVthanVeducationVforVphysicians.


ANS:VA
ImplementationVofVtheVAffordableVCareVActVhasVincreasedVtheVnumberVofVindividualsVwithV
healthVcareVcoverage,VandVthusVtheVnumberVwhoVhaveVaccessVtoVhealthVcareVservices.VTheV
increaseVinVtheVnumberVofVpatientsVcreatesVtheVneedVforVmoreVprovidersVwithVprescriptiveV
authority.VAPRNsVcanVfillVthisVpracticeVgap.VDIF:VCognitiveVLevel:VComprehensionVREF:V
p.V2TOP:VNursingVProcess:VImplementationVMSC:VNCLEXVClientVNeedsVCategory:VPhysio
logicVIntegrity:VPharmacologicVandVParenteralVTherapies
MedCV©V202
2

,3. WhichVfactorsVcouldVbeVattributedVtoVlimitedVprescriptiveVauthorityVforVAPRNs?VSel
ectVallVthatVapply.
a. InaccessibilityVofVpatientVcare
b. HigherVhealthVcareVcosts
c. HigherVqualityVmedicalVtreatment
d. ImprovedVcollaborativeVcare
e. EnhancedVhealthVliteracy


ANS:VAV,VB
LimitingVprescriptiveVauthorityVforVAPRNsVcanVcreateVbarriersVtoVquality,Vaffordable,VandV
accessibleVpatientVcare.VItVmayValsoVleadVtoVpoorVcollaborationVamongVprovidersVandVhighe
rVhealthVcareVcosts.VItVwouldVnotVdirectlyVimpactVpatient‘sVhealthVliteracy.DIF:VCognitiveV
Level:VComprehensionREF:
p.V2TOP:VNursingVProcess:VImplementationVMSC:VNCLEXVClientVNeedsVCategory:VPhysiol
ogicVIntegrity:VPharmacologicVandVParenteralVTherapies


4. WhichVaspectsVsupportVtheVAPRN‘sVprovisionVforVfullVprescriptiveVauthority?VSel
ectVallVthatVapply.


a. ClinicalVeducationVincludesVprescriptionVofVmedicationsVandVdiseaseVprocesses.
b. FederalVregulationsVsupportVtheVprovisionVofVfullVauthorityVforVAPRNs.
c. NationalVexaminationsVprovideVvalidationVofVtheVAPRN‘sVabilityVtoVprovideVsafecare.
d. LicensureVensuresVcomplianceVwithVhealthVcareVandVsafetyVstandards.
e. LimitingVprovisionVcanVdecreaseVhealthVcareVaffordability.


ANS:VAV,VCV,VD
APRNsVareVeducatedVtoVpracticeVandVprescribeVindependentlyVwithoutVsupervision.VNationa
lVexaminationsVvalidateVtheVabilityVtoVprovideVsafeVandVcompetentVcare.VLicensureVensures
VcomplianceVwithVstandardsVtoVpromoteVpublicVhealthVandVsafety.VLimitedVprescriptiveVauth
orityVcreatesVnumerousVbarriersVtoVquality,Vaffordable,VandVaccessibleVpatientVcare.DIF:VCo
gnitiveVLevel:VComprehensionREF:Vpp.V1-
2TOP:VNursingVProcess:VImplementationVMSC:VNCLEXVClientVNeedsVCategory:VPhysiolog
icVIntegrity:VPharmacologicVandVParenteralVTherapies
5. WhichVaspectsVsupportVtheVAPRN‘sVprovisionVforVfullVprescriptiveVauthority?VSelect
MedCV©V202
2

,allthatVapply.


a. ClinicalVeducationVincludesVprescriptionVofVmedicationsVandVdiseaseVprocesses.
b. FederalVregulationsVsupportVtheVprovisionVofVfullVauthorityVforVAPRNs.
c. NationalVexaminationsVprovideVvalidationVofVtheVAPRN‘sVabilityVtoVprovideVsafecare.
d. LicensureVensuresVcomplianceVwithVhealthVcareVandVsafetyVstandards.


ANS:VAV,VCV,VD
APRNsVareVeducatedVtoVpracticeVandVprescribeVindependentlyVwithoutVsupervision.VNationa
lVexaminationsVvalidateVtheVabilityVtoVprovideVsafeVandVcompetentVcare.VLicensureVensures
VcomplianceVwithVstandardsVtoVpromoteVpublicVhealthVandVsafety.VLimitedVprescriptiveVauth
orityVcreatesVnumerousVbarriersVtoVquality,Vaffordable,VandVaccessibleVpatientVcare.DIF:VCo
gnitiveVLevel:


ComprehensionVREF:Vpp.V 1-2TOP:VNursingVProcess:VImplementation
MSC:VNCLEXVClie
ntVNeedsVCategory:VPhysiologicVIntegrity:VPharmacologicVandVParenteralVTherapies




6. AVfamilyVnurseVpractitionerVpracticingVinVMaineVisVhiredVatVaVpracticeVacrossVstate
VlinesVinVVirginia.VWhichVaspectVofVpracticeVmayVchangeVforVtheVAPRN?

a. TheVAPRNVwillVhaveVlessVprescriptiveVauthorityVinVtheVnewVposition.
b. TheVAPRNVwillVhaveVmoreVprescriptiveVauthorityVinVtheVnewVposition.
c. TheVAPRNVwillVhaveVequalVprescriptiveVauthorityVinVtheVnewVposition.
d. TheVAPRN‘sVauthorityVwillVdependVonVfederalVregulati
ons.VANS:VA
VirginiaVallowsVlimitedVprescriptiveVauthority,VwhileVMaineVgivesVfullVauthorityVtoVcertified
VnurseVpractitioners.VTheVfederalVgovernmentVdoesVnotVregulateVprescriptiveVauthority.DIF:V
CognitiveVLevel:VComprehensionREF:Vp.V3TOP:VNursingVProcess:VImplementationVMSC:V
NCLEXVClientVNeedsVCategory:VPhysiologicVIntegrity:VPharmacologicVandVParenteralVTher
apies
Rosenthal:VLehne'sVPharmacotherapeuticsVforVAdvancedVPracticeVProviders,V2ndVEd.V
ChapterV2:VRationalVDrugVSelectionVandVPrescriptionVWriting
TestVBankVMultipleVChoice
MedCV©V202
2

, 7. HowVcanVcollaborationVwithVaVpharmacistVimproveVpositiveVoutcomesVforVpatients?V
SelectVallVthatVapply.


a. PharmacistsVcanVsuggestVfoodsVthatVwillVhelpVwithVtheVpatient‘sVcondition.
b. PharmacistsVhaveVadditionalVinformationVonVdrugVinteractions.
c. TheVpharmacistVcanVsuggestVadequateVmedicationVdosing.
d. PharmacistsVhaveVfirsthandVknowledgeVofVtheVfacilityVformulary.
e. PharmacyVcanValterVprescriptionsVwhenVnecessaryVtoVpreventVpatientVharm.


ANS:VBV,VCV,VD
ProvidersVshouldVcollaborateVwithVpharmacistsVbecauseVtheyVwillVlikelyVhaveVadditionalVinf
ormationVonVformulary,VdrugVinteractions,VandVsuggestionsVforVadequateVmedicationVdosing.
VDietitiansVcanVmakeVfoodsVrecommendationsVtoVtreatVtheVpatient‘sVcondition.VTheVpharmac
istVcanVcontactVtheVprescriberVaboutVquestionableVprescriptions,VbutVcannotValterVtheVprescri
ptionVwithoutVnotificationVofVandVapprovalVbyVtheVprovider.DIF:VCognitiveVLevel:VCompre
hensionREF:Vp.
9TOP:VNursingVProcess:VDiagnosisVMSC:VNCLEXVClientVNeedsVCategory:VPhysiologicVInte
grity:VReductionVofVRiskVPotential


8. AVpatientVpresentsVwithVdeliriumtremensVrequiringVAtivanVadministration.VTheVpro
viderVofcareVisVnotVinVtheVfacility.VWhichVactionVbyVtheVnurseVisVmostVappropriate?


a. ObtainVaVtelephoneVorder.
b. ContactVtheVon-callVhospitalist.
c. ObtainVanVorderVfromVtheVchargeVnurse.
d. WaitVforVaVwrittenVAtivanVorder.


ANS:VA
InVanVemergencyVsituation,VsuchVasVdeliriumVtremensVwithVseizureVactivity,VitVisVacceptabl
eVtoVprovideVaVtelephoneVorder.VContactingVtheVon-
callVhospitalistVorVwaitingVforVaVwrittenVorderVwouldVtakeVmoreVtimeVthanVavailableVforVaV
patientVwithVhighVseizureVrisk.VWritingVanVorderVisVoutsideVtheVscopeVofVpracticeVforVtheVc
hargeVnurse.DIF:VCognitiveVLevel:VApplicationREF:Vp.V7TOP:VNursingVProcess:VImplement
ationVMSC:VNCLEXVClientVNeedsVCategory:VPhysiologicVIntegrity:VReductionVofVRiskVPot
MedCV©V202
2